Cobalt Chromium Coronary Stent Delivery System
- UID
- MFG/MD/2020/000086_ccdd0b64f12c7c67c537f938e6f67542_21760898122ef07b9d8847b6bc44b62d
- Device class
- Class D
- Brand name
- TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM
- License holder
- Relisys Medical Devices Limited
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- The Relisys Cobalt chromium coronary stent system is indicated for improving luminal diameter and reducing restenosis for the treatment of de novo lesions in native coronary arteries in the following: • Patients with symptomatic ischemic heart disease due to discrete de novo or restenotic native coronary artery lesions • Patients with symptomatic ischemic heart disease due to lesions in saphenous vein bypass grafts. • Restoring coronary flow in patients experiencing acute myocardial infarction, as confirmed by ST-segment elevation or angiographic findings, who present within 12 hours of symptom onset with native coronary artery lesions
Cobalt Chromium Coronary Stent Delivery System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000086_ccdd0b64f12c7c67c537f938e6f67542_21760898122ef07b9d8847b6bc44b62d. This device is marketed under the brand name TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM. The license holder is Relisys Medical Devices Limited, and it is classified as Device Class Class D. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.